Pisa syndrome as a motor complication of Parkinson's disease

被引:28
作者
Kim, Joong-Seok
Park, Jeong-Wook
Chung, Sung-Woo
Kim, Yeong-In
Kim, Hee-Tae
Lee, Kwang-Soo
机构
[1] Department of Neurology, The Catholic University of Korea
[2] Department of Neurology, College of Medicine, Hanyang University
关键词
Pisa syndrome; Parkinson's disease; motor complication;
D O I
10.1016/j.parkreldis.2006.03.010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We describe two elderly patients with a convincing clinical diagnosis of Parkinson's disease (PD) who developed axial end-of-dose/off dystonia, also referred to as Pisa syndrome (PS). The worsening of symptoms in the "off" period, and a favorable response of the dystonia to an increase of levodopa suggests that PS in our patients may be primarily related to a manifestation of motor fluctuations in PD. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:126 / 128
页数:3
相关论文
共 8 条
[1]  
Bhattacharya KF, 2000, MOVEMENT DISORD, V15, P1285, DOI 10.1002/1531-8257(200011)15:6<1285::AID-MDS1044>3.0.CO
[2]  
2-U
[3]   SCOLIOSIS OF PARKINSONISM - NOTE [J].
DUVOISIN, RC ;
MARSDEN, CD .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1975, 38 (08) :787-793
[4]   Pisa syndrome without neuroleptic exposure in a patient with Parkinson's disease: Case report [J].
Gambarin, M ;
Antonini, A ;
Moretto, G ;
Bovi, P ;
Romito, S ;
Fiaschi, A ;
Tinazzi, M .
MOVEMENT DISORDERS, 2006, 21 (02) :270-273
[5]   Marked asymmetry of putaminal pathology in an MSA-P patient with Pisa syndrome [J].
Hozumi, I ;
Piao, YS ;
Inuzuka, T ;
Matsuyama, Z ;
Yamada, Y ;
Hara, A ;
Hirose, T ;
Tsuchiya, K ;
Takahashi, H .
MOVEMENT DISORDERS, 2004, 19 (04) :470-472
[6]  
Patel S, 1991, J Geriatr Psychiatry Neurol, V4, P48, DOI 10.1177/089198879100400109
[7]   Drug-induced Pisa syndrome (pleurothotonus) - Epidemiology and management [J].
Suzuki, T ;
Matsuzaka, H .
CNS DRUGS, 2002, 16 (03) :165-174
[8]   Cholinergic-dopaminergic imbalance in Pisa syndrome [J].
Villarejo, A ;
Camacho, A ;
García-Ramos, R ;
Moreno, T ;
Penas, M ;
Juntas, R ;
Ruiz, J .
CLINICAL NEUROPHARMACOLOGY, 2003, 26 (03) :119-121